Sponsor Pipeline

Immatics US, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06743126 SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated… Melanoma, Cutaneous Malignant Recruiting
Phase 1/2
NCT03686124 ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent… Refractory Cancer Recruiting
Phase 1
NCT06946225 ACTengine® IMA203 Combined With mRNA-4203 Cutaneous Melanoma Recruiting
Disease Areas
Melanoma (2) Sarcoma (1)
Get alerts when Immatics US, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free